Inventor
MIN TENG
Inventor
US
Overview
Patents· 7 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations26%
A61KPreparations for medical, dental or toiletry purposes16%
Y02ATechnologies for adaptation to climate change16%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium5%
LOC045%
PatentTitleYear
D1107431Oral care implement handle202512,325,699Antibacterial compounds202512,187,754LpxC inhibitors and uses thereof202511,780,853Substituted N-pyrimidin-4-yl-3-aminopyrrolo[3,4-C]pyrazoles as protein kinase C inhibitors202311,731,962LpxC inhibitor and methods of making202311,407,740Antibacterial compounds202211,220,518Substituted n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazoles as protein kinase C inhibitors2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2023Patents assigned to PFIZER (2)· patent assignee history
2022Patents assigned to FORGE THERAPEUTICS INC (1)· patent assignee history
2022–2025Based in US· patent location history
2023–2025Patents assigned to BLACKSMITH MEDICINES INC (3)· patent assignee history
2025Patents assigned to COLGATE PALMOLIVE CO (1)· patent assignee history
2025Based in CN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BLACKSMITH MEDICINES INC | 3 | 2023–2025 |
| PFIZER | 2 | 2022–2023 |
| COLGATE PALMOLIVE CO | 1 | 2025 |
| FORGE THERAPEUTICS INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2022–2025 |
| CN | 1 | 2025 |